You are viewing: Rest Of Europe IVD Raw Material Market analysis
Part of: IVD Raw Material Market (Global)

The Rest Of Europe IVD Raw Material Market was valued at $723.9 Million in 2026 and projected to reach to $1126.8 Million by 2031, representing a compound annual growth rate of 9.3%. Rest Of Europe represents a dynamic and underutilized segment within the European IVD raw material landscape, characterized by emerging diagnostic markets and expanding healthcare infrastructure.

Rest Of Europe IVD Raw Material Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe IVD Raw Material Market Trends and Insights

  • The region is experiencing robust growth driven by increasing diagnostic demand, regulatory harmonization, and expanding healthcare infrastructure across non-major European markets.
  • Rest Of Europe is projected to expand to USD 1,126.8 million by 2031, reflecting a compound annual growth rate of 9.3%, outpacing the global average of 7.7%. The accelerated growth trajectory in Rest Of Europe is underpinned by rising investments in laboratory automation, growing prevalence of chronic diseases, and strengthening supply chain networks for raw material procurement.
  • Rest Of Europe's market expansion is supported by emerging economies within the region adopting advanced diagnostic technologies and increasing healthcare spending.
  • Between 2026 and 2031, Rest Of Europe will witness substantial consolidation in raw material sourcing, with manufacturers prioritizing quality assurance and regulatory compliance to meet evolving European standards..

Key Market Statistics

  • CAGR (2026-2031) 9.3% CAGR
  • Market Size, 2026 ~USD 723.9 Million
  • Forecast, 2031 ~USD 1126.8 Million
  • Country Rest Of Europe

Rest Of Europe IVD Raw Material Market Overview

Strong Regional Growth Trajectory :

Rest Of Europe's IVD raw material market is expanding at 9.3% CAGR, outpacing the global average of 7.7%, indicating accelerating adoption and market maturation across secondary European markets.

Significant Market Expansion :

The market is projected to grow from USD 723.9 million in 2026 to USD 1,126.8 million by 2031, representing a 55.7% increase over five years, driven by diagnostic infrastructure development.

Regulatory Harmonization Benefits :

Increasing alignment with EU regulatory standards across Rest Of Europe countries is streamlining market entry and reducing compliance barriers for IVD raw material suppliers and manufacturers.

Healthcare Infrastructure Expansion :

Growing investment in diagnostic capabilities and laboratory modernization across non-major European markets is creating sustained demand for high-quality IVD raw materials and specialized components.

Rest Of Europe IVD Raw Material Market Dynamics

  • The region's 9.3% CAGR reflects increasing healthcare spending, rising disease prevalence, and growing adoption of advanced diagnostic technologies across secondary markets.
  • Regulatory harmonization with EU standards is facilitating market consolidation and attracting multinational suppliers. By 2031, Rest Of Europe is positioned to become a more substantial market contributor, driven by laboratory modernization initiatives, increased point-of-care testing adoption, and enhanced disease screening programs.
  • Strategic investments in healthcare infrastructure and rising awareness of preventive diagnostics will continue to fuel demand for specialized IVD raw materials, creating opportunities for both established and emerging market participants..

Market Ecosystem

logo-mobile

IVD RAW MATERIAL MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Supplies antibodies, antigens, recombinant proteins, enzymes, membranes, and other critical raw materials used in the development of immunoassays, molecular diagnostics, and point-of-care tests. Enables high assay sensitivity and specificity, ensures consistent test performance, and supports scalable diagnostic manufacturing.
company logo
Provides a broad portfolio of antibodies, proteins, enzymes, nucleic acids, and specialty reagents for diagnostic assay development and commercialization. Supports reliable assay development, improves diagnostic accuracy, and accelerates time-to-market for IVD manufacturers.
company logo
Develops and manufactures diagnostic-grade antibodies, antigens, and assay components for immunodiagnostic and rapid testing applications. Enhances assay performance, ensures batch-to-batch consistency, and supports high-quality diagnostic outcomes.
company logo
Offers recombinant proteins, antibodies, immunoassay reagents, and molecular diagnostic raw materials for clinical and research diagnostic applications. Provides high analytical sensitivity, supports biomarker detection, and enables development of advanced diagnostic tests.
company logo
Supplies integrated raw material solutions including antibodies, antigens, enzymes, and detection reagents for immunoassays and point-of-care diagnostics. Facilitates cost-effective assay development, improves diagnostic reliability, and supports large-scale manufacturing requirements.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Rest Of Europe's IVD raw material market is valued at USD 723.9 million in 2026 and will grow to USD 1,126.8 million by 2031.
    • Rest Of Europe demonstrates a 9.3% CAGR, exceeding the global growth rate of 7.7% during the forecast period.
    • Rest Of Europe's growth is driven by regulatory harmonization, laboratory automation adoption, and expanding healthcare infrastructure.
    • Rest Of Europe will see increased consolidation and quality-focused sourcing strategies among raw material manufacturers through 2031.

    IVD Raw Material Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
    Forecast Period 2026-2031
    Growth Rate CAGR of 7.7% from 2026 to 2031
    Largest Segment IVD MANUFACTURERS (End User)
    Market Size Base Year (Billions) ~USD 21.46 (2026)
    Revenue Forecast (Billions) ~USD 31.1 (2031)
    Segments Covered Product Type, Type, Technology, Application, Supply Source, Source/Origin, End User

    Rest Of Europe IVD Raw Material Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Product Type

    • Antibodies
    • Antigens & Proteins
    • Beads & Particles
    • Buffers & Diluents
    • Enzymes & Substrates
    • Labels & Detection Materials
    • Membranes
    • Oligonucleotides & Nucleic Acids
    • Other Products

    By Type

    • Academic & Research Institutes
    • Amplification Enzymes
    • Animal-Derived
    • Calibrators & Standards
    • Chemically Synthesized
    • Chemiluminescent Labels
    • Cho-Expressed
    • Colloidal Gold Conjugates
    • Cros
    • Detection Enzymes
    • E. Coli-Expressed
    • Fluorescent Dyes
    • Glass Fiber Pads
    • Gold Nanoparticles
    • Human-Derived
    • Ivd Manufacturers
    • Latex Particles
    • Magnetic Beads
    • Monoclonal Antibodies
    • Native Proteins
    • Nitrocellulose Membranes
    • Nylon & Pvdf Membranes
    • Other End Users
    • Pharmaceutical & Biotechnology Companies
    • Polyclonal Antibodies
    • Primers & Probes
    • Recombinant Antibodies
    • Recombinant Antigens
    • Substrates & Coenzymes
    • Synthetic Dna/Rna

    By Technology

    • Clinical Chemistry
    • Coagulation Testing
    • Flow Cytometry
    • Hematology
    • Immunoassay
    • Microbiology & Culture
    • Molecular Diagnostics
    • Other Technologies

    By Application

    • Autoimmune Diseases
    • Blood Screening
    • Cardiac Markers
    • Diabetes & Metabolic Disorders
    • Genetic & Rare Disease Testing
    • Infectious Diseases
    • Oncology/Cancer Markers
    • Other Applications
    • Women'S Health & Fertility

    By Supply Source

    • In-House Manufacturing
    • Third-Party Supply

    By Source/Origin

    • Biological/Natural Sources
    • Other Sources
    • Recombinant/ Synthetic Sources
    • Recombinant/Synthetic Sources

    By End User

    • Academic & Research Institutes
    • Cros
    • Ivd Manufacturers
    • Other End Users
    • Pharmaceutical & Biotechnology Companies

    Target Audience

    • IVD Raw Material Manufacturers : Manufacturers need Rest Of Europe-specific data to identify market entry opportunities, assess competitive intensity, and develop regional supply chain strategies for this high-growth secondary market segment.
    • Diagnostic Equipment Suppliers : Equipment manufacturers require detailed insights into Rest Of Europe's raw material demand patterns and regulatory requirements to optimize product specifications and establish reliable supplier partnerships.
    • Healthcare Investment Firms : Private equity and venture capital investors need Rest Of Europe market analysis to evaluate investment opportunities, assess growth potential, and identify acquisition targets in the expanding diagnostic sector.
    • Laboratory Service Providers : Clinical and reference laboratories need Rest Of Europe market intelligence to forecast raw material costs, identify reliable suppliers, and plan capacity expansion aligned with regional diagnostic demand.
    • Strategic Business Consultants : Consultants advising healthcare and diagnostics clients require Rest Of Europe-specific market data to develop market entry strategies, competitive positioning recommendations, and growth roadmaps for the region.

    Reasons to Buy this Report

    • Regional Market Differentiation : Gain specific insights into Rest Of Europe's unique market dynamics, distinct from major European markets, enabling targeted go-to-market strategies and localized product development for secondary European countries.
    • High-Growth Opportunity Identification : Identify emerging opportunities in the fastest-growing European segment with 9.3% CAGR, outpacing global growth, allowing early-mover advantages in underserved diagnostic markets across Rest Of Europe.
    • Regulatory Compliance Roadmap : Access detailed analysis of regulatory harmonization trends and compliance requirements specific to Rest Of Europe, reducing market entry risks and accelerating commercialization timelines for IVD raw material products.
    • Competitive Landscape Intelligence : Understand competitive positioning, supplier dynamics, and market consolidation patterns unique to Rest Of Europe, enabling informed partnership and acquisition strategies in this growing segment.
    • Investment Decision Support : Leverage comprehensive market sizing and five-year forecasts (USD 723.9M to USD 1,126.8M) to justify capital allocation, secure funding, and develop credible business cases for Rest Of Europe expansion.

    Frequently asked questions

    What is the current market size of IVD raw materials in Rest Of Europe?

    Rest Of Europe's IVD raw material market is estimated at USD 723.9 million in 2026.

    What is the projected market size for Rest Of Europe by 2031?

    Rest Of Europe's IVD raw material market is forecasted to reach USD 1,126.8 million by 2031.

    What is the CAGR for Rest Of Europe's IVD raw material market?

    Rest Of Europe's IVD raw material market is expected to grow at a CAGR of 9.3% from 2026 to 2031.

    How does Rest Of Europe's growth compare to global trends?

    Rest Of Europe's 9.3% CAGR outpaces the global average of 7.7%, indicating stronger regional market momentum.

    What factors are driving growth in Rest Of Europe's IVD raw material market?

    Rest Of Europe's growth is driven by regulatory harmonization, laboratory automation adoption, chronic disease prevalence, and expanding healthcare infrastructure.

    RESEARCH METHODOLOGY

    The objective of this study is to analyze the key dynamics influencing the IVD raw material market, including drivers, restraints, opportunities, challenges, and emerging technology trends. The study also evaluates competitive developments, including product launches, regulatory approvals, acquisitions, partnerships, collaborations, and geographic expansions undertaken by leading market participants. Furthermore, it assesses the competitive landscape of the IVD raw material market by profiling key players and benchmarking them across various business and product strategy parameters. Both top-down and bottom-up approaches were employed to estimate the overall market size, while market breakdown and data triangulation methodologies were used to validate the size of individual segments and subsegments and ensure the accuracy of market estimates.

    The four steps involved in estimating the market size are as follows:

    Secondary Research

    Secondary research for the IVD raw material market drew on a wide range of credible commercial and regulatory sources, including Bloomberg Business, Factiva, and Dun & Bradstreet for corporate financial and operational data. White papers, scientific publications, annual reports, investor presentations, and SEC filings provided additional context on product pipelines, revenue structures, and market positioning. Regulatory databases were used to track device clearances and approvals in key geographies.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Supply-side primary interviews were conducted with project managers, product managers, sales directors, vice presidents of diagnostics, CEOs, and business development directors at manufacturers of IVD raw material, laboratory automation vendors, and IVD distributors. Demand-side primary interviews covered laboratory directors and clinical pathologists at hospital and reference laboratories, forensic laboratory managers, reproductive health clinic directors, academic research scientists, and procurement officers at pharmaceutical and biotechnology companies.

    The following is a breakdown of the primary respondents:

    IVD Raw Material Market Size, and Share

    Note: Others include sales, marketing, and product managers.
    Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

    COMPANY NAME

    DESIGNATION

    Merck KGaA (Germany)

    Sales Manager

    Thermo Fisher Scientific Inc. (US)

    Product Manager

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the IVD raw material market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the IVD raw material market were determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    IVD Raw Material Market : Top-Down and Bottom-Up Approach

    IVD Raw Material Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the overall market size using the process described above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed to validate and complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments of the IVD raw material market. The data was triangulated by examining various factors and trends on the demand and supply sides of the IVD raw material market.

    Market Definition

    The IVD raw material market is the industry involved in the development, production, and supply of biological, chemical, and synthetic components used in manufacturing in vitro diagnostic (IVD) assays and testing systems. These raw materials include antibodies, antigens, proteins, enzymes, substrates, oligonucleotides, nucleic acids, beads and particles, membranes, labels and detection materials, buffers, diluents, and other specialized reagents that serve as critical building blocks for diagnostic tests. IVD raw materials are utilized across a wide range of diagnostic technologies. These materials play a vital role in ensuring the accuracy, sensitivity, specificity, and reliability of diagnostic tests used to detect, diagnose, screen for, monitor, and prognose health-related conditions.

    Key Stakeholders

    • IVD Raw Material Manufacturers and Suppliers
    • IVD Manufacturers (OEMs/Diagnostic Kit Manufacturers)
    • Contract Research Organizations (CROs) and Contract Development & Manufacturing Organizations (CDMOs)
    • Diagnostic Laboratories and Clinical Testing Laboratories
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Research and Development (R&D) Centers
    • Distributors and Channel Partners
    • Regulatory and Quality Compliance Organizations
    • Healthcare Institutions and Diagnostic Service Providers

    Report Objectives

    • To define, describe, and forecast the IVD raw material market by product type, technology, application, supply source, source/origin, end user, and region
    • To provide detailed information about the key factors influencing the growth of the IVD raw material market (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide the competitive landscape details of the key players
    • To forecast the revenue of market segments across five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players of the IVD raw material market and comprehensively analyze their core competencies and market shares
    • To benchmark players within the market using the proprietary company evaluation matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
    • To study the impact of AI on the market, along with the macroeconomic outlook for each region

    Available customizations:

    MarketsandMarkets offers the following customizations for this market report.

    Country Information

    • Additional country-level analysis of the IVD raw material market

    Company Profiles

    • Additional five company profiles of players operating in the IVD raw material market.

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the IVD raw material market

    Get the Full IVD Raw Material Market Report

    Full forecast, segment splits, and company analysis for all IVD Raw Material Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status